Life Cycle of Orphan Drug Development & Commercialization 2013 is a conference dedicated to
- Rare disease research units for large and niche pharma companies
- Rare disease research methods used in early stages of orphan drug development
- How to increase patient recruitment in clinical trials
- Translational medicine to be effective in orphan drug development
- FDA Safety and Innovation Act and its impact on orphan drug reserach and development
Who should Attend
Vice Presidents, Heads, Scientists and Directors responsible for: :
- Orphan Drug Development
- Rare Disease Discovery
- Research & Development
- Translational Research
- Regulatory Affairs
- Clinical Operations
- Reimbursement
